Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice.

Wang S, Welte T, Fang H, Chang GJ, Born WK, O'Brien RL, Sun B, Fujii H, Kosuna K, Wang T.

J Nutr. 2009 Mar;139(3):598-602. doi: 10.3945/jn.108.100297. Epub 2009 Jan 13.

2.

Role of two distinct gammadelta T cell subsets during West Nile virus infection.

Welte T, Lamb J, Anderson JF, Born WK, O'Brien RL, Wang T.

FEMS Immunol Med Microbiol. 2008 Jul;53(2):275-83. doi: 10.1111/j.1574-695X.2008.00430.x. Epub 2008 May 29.

3.

Dysregulation of Toll-Like Receptor 7 Compromises Innate and Adaptive T Cell Responses and Host Resistance to an Attenuated West Nile Virus Infection in Old Mice.

Xie G, Luo H, Pang L, Peng BH, Winkelmann E, McGruder B, Hesse J, Whiteman M, Campbell G, Milligan GN, Cong Y, Barrett AD, Wang T.

J Virol. 2015 Nov 18;90(3):1333-44. doi: 10.1128/JVI.02488-15. Print 2016 Feb 1.

4.

Baboon model for West Nile virus infection and vaccine evaluation.

Wolf RF, Papin JF, Hines-Boykin R, Chavez-Suarez M, White GL, Sakalian M, Dittmer DP.

Virology. 2006 Nov 10;355(1):44-51. Epub 2006 Aug 10.

5.

Vγ4+ T cells regulate host immune response to West Nile virus infection.

Welte T, Aronson J, Gong B, Rachamallu A, Mendell N, Tesh R, Paessler S, Born WK, O'Brien RL, Wang T.

FEMS Immunol Med Microbiol. 2011 Nov;63(2):183-92. doi: 10.1111/j.1574-695X.2011.00840.x.

6.

A critical role for induced IgM in the protection against West Nile virus infection.

Diamond MS, Sitati EM, Friend LD, Higgs S, Shrestha B, Engle M.

J Exp Med. 2003 Dec 15;198(12):1853-62. Epub 2003 Dec 8.

7.

CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system.

Sitati EM, Diamond MS.

J Virol. 2006 Dec;80(24):12060-9. Epub 2006 Oct 11.

8.

Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses.

Gao Y, Zhang D, Sun B, Fujii H, Kosuna K, Yin Z.

Cancer Immunol Immunother. 2006 Oct;55(10):1258-66. Epub 2005 Dec 16.

PMID:
16362410
9.

A Phase I study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers.

Spierings EL, Fujii H, Sun B, Walshe T.

J Nutr Sci Vitaminol (Tokyo). 2007 Dec;53(6):536-9.

10.

Active hexose correlated compound enhances resistance to Klebsiella pneumoniae infection in mice in the hindlimb-unloading model of spaceflight conditions.

Aviles H, Belay T, Fountain K, Vance M, Sun B, Sonnenfeld G.

J Appl Physiol (1985). 2003 Aug;95(2):491-6. Epub 2003 Apr 11.

11.

Short-term supplementation with active hexose correlated compound improves the antibody response to influenza B vaccine.

Roman BE, Beli E, Duriancik DM, Gardner EM.

Nutr Res. 2013 Jan;33(1):12-7. doi: 10.1016/j.nutres.2012.11.001. Epub 2012 Dec 4.

PMID:
23351405
12.

Impaired virus clearance, compromised immune response and increased mortality in type 2 diabetic mice infected with West Nile virus.

Kumar M, Roe K, Nerurkar PV, Namekar M, Orillo B, Verma S, Nerurkar VR.

PLoS One. 2012;7(8):e44682. doi: 10.1371/journal.pone.0044682. Epub 2012 Aug 31.

13.

Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.

Prince HE, Tobler LH, Lapé-Nixon M, Foster GA, Stramer SL, Busch MP.

J Clin Microbiol. 2005 Sep;43(9):4316-20.

14.

Experimental susceptibility of wood ducks (Aix sponsa) for West Nile virus.

Hofmeister E, Porter RE, Franson JC.

J Wildl Dis. 2015 Apr;51(2):411-8. doi: 10.7589/2014-08-216. Epub 2015 Jan 14.

PMID:
25588010
16.

West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses.

Johnson BW, Kosoy O, Martin DA, Noga AJ, Russell BJ, Johnson AA, Petersen LR.

Vector Borne Zoonotic Dis. 2005 Summer;5(2):137-45.

PMID:
16011430
17.

A hamster-derived West Nile virus isolate induces persistent renal infection in mice.

Saxena V, Xie G, Li B, Farris T, Welte T, Gong B, Boor P, Wu P, Tang SJ, Tesh R, Wang T.

PLoS Negl Trop Dis. 2013 Jun 13;7(6):e2275. doi: 10.1371/journal.pntd.0002275. Print 2013.

18.

Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.

Magnusson SE, Karlsson KH, Reimer JM, Corbach-Söhle S, Patel S, Richner JM, Nowotny N, Barzon L, Bengtsson KL, Ulbert S, Diamond MS, Stertman L.

Vaccine. 2014 Feb 7;32(7):800-8. doi: 10.1016/j.vaccine.2013.12.030. Epub 2013 Dec 28.

PMID:
24380682
19.

Active hexose correlated compound enhances the immune function of mice in the hindlimb-unloading model of spaceflight conditions.

Aviles H, Belay T, Vance M, Sun B, Sonnenfeld G.

J Appl Physiol (1985). 2004 Oct;97(4):1437-44. Epub 2004 Jun 11.

20.

Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection.

Shrestha B, Wang T, Samuel MA, Whitby K, Craft J, Fikrig E, Diamond MS.

J Virol. 2006 Jun;80(11):5338-48.

Supplemental Content

Support Center